Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.

NCT00429065 · clinicaltrials.gov ↗

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Non-Hodgkin Lymphoma

Interventions

DRUG: Rituximab

Sponsor

Instituto Nacional de Cancerologia de Mexico